OncoSec Medical Return on Equity

OncoSec Medical (ONCS) currently reports a ROE of 549.36%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore OncoSec Medical's ROE history and peer comparisons.

OncoSec Medical's ROE of 549.36% is higher than the Healthcare sector average of -75.84%. That is roughly 824.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but OncoSec Medical's current 549.36% should be judged against Healthcare norms (sector average: -75.84%) and against ONCS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 549.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for OncoSec Medical, and consider following ONCS for alerts when major investors trade the stock.

OncoSec Medical is classified in the Healthcare sector. On ROE, it currently shows 549.36% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONCS with unrelated industries.